Pulmonary Thromboembolism References

Last updated: 25 June 2025
  1. Almoosa K. Is thrombolytic therapy effective for the pulmonary embolism?. Am Fam Physician. 2002 Mar;65(6):1097-1102. PMID: 11925086
  2. Büller HR, Agnelli G, Hull RD, et al. Antithrombotic therapy for venous thromboembolic disease: the seventh ACCP Conference on antithrombotic and thrombolytic therapy. Chest. 2004 Sep;126(3)(Suppl):401S-428S. PMID: 15383479
  3. British Thoracic Society Standards of Care Committee Pulmonary Embolism Guideline Development Group. British Thoracic Society guidelines for the management of suspected acute pulmonary embolism. Thorax. 2003 Jun;58(6):470-484. doi: 10.1136/thorax.58.6.470. PMID: 12775856
  4. American College of Emergency Physicians (ACEP) Clinical Policies Committee; Clinical Policies Committee Subcommittee on Suspected Pulmonary Embolism. Clinical policy: critical issues in the evaluation and management of adult patients presenting with suspected pulmonary embolism. Ann Emerg Med. 2003 Feb;41(2):257-270. PMID: 12548278
  5. Goldhaber SZ. Modern treatment of pulmonary embolism. Eur Respir J Suppl. 2002 Feb;35:22S-27S. PMID: 12064677
  6. Iles S, Beckert L, Than M, et al. Making a diagnosis of pulmonary embolism - new methods and clinical issues. N Z Med J. 2003 Jul;116(1177):U499. PMID: 12861313
  7. Hirsh J, Warkentin TE, Shaughnessy SG, et al. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest. 2001 Jan;119(1)(Suppl Suppl):S64-S94. doi: 10.1378/chest.119.1_suppl.64s. PMID: 11157643
  8. Kearon C, Kahn SR, Agnelli G, et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008 Jun;133(6)(Suppl Suppl):454S-545S. doi: 10.1378/chest.08-0658. PMID: 18574272
  9. Quinlan DJ, McQuillan A, Eikelboom JW. Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta-analysis of randomized, controlled trials. Ann Intern Med. 2004 Feb;140(3):175-183. doi: 10.7326/0003-4819-140-3-200402030-00008. PMID: 14757615
  10. Ramzi DW, Leeper KV. DVT and pulmonary embolism: Part II. Treatment and prevention. Am Fam Physician. 2004 Jun;69(12):2841-2848. PMID: 15222649
  11. Kearon C. Diagnosis of pulmonary embolism. CMAJ. 2003 Jan;168(2):183-194. PMID: 12538548
  12. Task Force on Pulmonary Embolism, European Society of Cardiology. Guidelines on diagnosis and management of acute pulmonary embolism. Eur Heart J. 2000 Aug;21(16):1301-1336. PMID: 10952823
  13. Stein PD, Woodard PK, Hull RD, et al. Gadolinium-enhanced magnetic resonance angiography for detection of acute pulmonary embolism: an in-depth review. Chest. 2003 Dec;124(6):2324-2328. doi: 10.1016/s0012-3692(15)31694-9. PMID: 14665516
  14. Snow V, Qaseem A, Barry P, et al. Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med. 2007 Feb;146(3):204-210. PMID: 17261857
  15. Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J. 2008 Sep 30 Aug 2008;29(18):2276-2315. doi: 10.1093/eurheartj/ehn310. Accessed 30 Aug 2008. PMID: 18757870
  16. Dupras D, Bluhm J, Felty C, et al. Institute for Clinical Systems Improvement. Venous thromboembolism diagnosis and treatment. 13th ed. 2013 Jan:001-91. Accessed 18 Sep 2012
  17. Creager MA, Dzau VJ. Vascular diseases of the extremities. In: Fauci AS, Braunwald E, Isselbacher KJ, et al. Harrison's Principles of Internal Medicine. 14th ed: McGraw-Hill; 1998:1404-1405
  18. Sue DY, Vintch JRE. Pulmonary disease. In: Bongard FS, Sue DY, Vintch JRE, eds. Current diagnosis & treatment critical care. 3rd ed. New York: McGraw-Hill; 2008:545-561
  19. MedWormhttp://www.medworm.com/rss/index.php/Pediatrics/33/http://www.medworm.com/rss/medicalfeeds/specialities/Pediatrics.xml
  20. MedWormhttp://www.medworm.com/rss/index.php/Respiratory-Medicine/40/http://www.medworm.com/rss/medicalfeeds/specialities/Respiratory-Medicine.xml
  21. Anticoagulants, antiplatelets and fibrinolystics. MIMS. www.mims.com. 2010. Accessed 13 Jan 2010
  22. Scottish Intercollegiate Guidelines Network. Prevention and management of venous thromboembolism: national meeting draft. SIGN. http://www.sign.ac.uk. Sep 2009. Accessed 13 Jan 2010
  23. Tapson VF. Massive pulmonary embolism. UpToDate. http://www.uptodate.com. 02 Sep 2004
  24. Institute for Clinical Systems Improvement (ICSI). Health care guideline: venous thromboembolism diagnosis and treatment. 9th ed. http://www.icsi.org. Feb 2009. Accessed 13 Jan 2010
  25. Tapson VF. Thrombolytic therapy in venous thromboembolism. UpToDate. http://www.uptodate.com. 02 Sep 2004. Accessed 26 Jan 2012.
  26. Ageno W, Gallus AS, Wittkowsky A, Crowther M, Hylek EM, Palareti G; American College of Chest Physicians. Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb;141(Suppl 2):e44S-88S. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278051/pdf/112292.pdf. PMID: 22315269
  27. Dupras D, Bluhm J, Felty C, et al. Institute for Clinical Systems Improvement (ICSI). Health care guideline: venous thromboembolism diagnosis and treatment. 13th ed. ICSI. https://www.icsi.org/. Jan 2013. Accessed 23 Apr 2015.
  28. Garcia DA, Baglin TP, Weitz JI, Samama MM; American College of Chest Physicians. Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb;141(Suppl 2):e24S-43S. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278070/pdf/112291.pdf. PMID: 22315264
  29. Linkins LA, Dans AL, Moores LK, et al; American College of Chest Physicians. Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb;141(Suppl 2):e495S-e530S. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278058/pdf/112303.pdf. Accessed 18 Jul 2014. PMID: 22315270
  30. Scottish Intercollegiate Guidelines Network (SIGN). Prevention and management of venous thromboembolism. SIGN publication no. 122. Scottish Intercollegiate Guidelines Network (SIGN). http://www.sign.ac.uk/pdf/sign122.pdf. 2010. Accessed 17 Jul 2014.
  31. Boehringer Ingelheim. FDA approves Pradaxa® (dabigatran etexilate mesylate) for treatment and reduction in the risk of recurrence of deep venous thrombosis and pulmonary embolism. Boehringer Ingelheim. http://us.boehringer-ingelheim.com/news_events/press_releases/press_release_archive/2014/04-07-14-fda-approves-pradaxa-dabigatran-etexilate-mesylate-treatment-reduction-risk-of-recurrence-deep-venous-thrombosis-pulmonary-embolism.html#. April 2014. Accessed 11 Sep 2014.
  32. Schulman S, Kakkar AK, Goldhaber SZ, et al; RE-COVER II Trial Investigators. Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis. Circulation. 2014 Feb;129(7):764-772. http://circ.ahajournals.org/content/129/7/764.full.pdf. Accessed 11 Sep 2014. PMID: 24344086
  33. Scottish Intercollegiate Guidelines Network (SIGN). Antithrombotics: indications and management. SIGN publication no. 129. Scottish Intercollegiate Guidelines Network (SIGN). http://www.sign.ac.uk/pdf/SIGN129.pdf. June 2013. Accessed 11 Sep 2014.
  34. Kearon C, Akl EA, Ornelas J, et al. Antithrombotic therapy for VTE disease: CHEST Guideline and Expert Panel report. Chest. 2016 Feb;149(2):315-352. doi: 10.1016/j.chest.2015.11.026. Accessed 08 Jun 2016. PMID: 26867832
  35. Aggarwal V, Nicolais CD, Lee A, Bashir R. Acute management of pulmonary embolism. American College of Cardiology. https://www.acc.org/. Oct 2017.
  36. Lip G, Hull R. Venous thromboembolism: Initiation of anticoagulation. UpToDate. https://www.uptodate.com/. 03 Jan 2024.
  37. National Institute for Health & Care Excellence (NICE). Percutaneous thrombectomy for intermediate-risk or high-risk pulmonary embolism. NICE. https://www.nice.org.uk/. 02 Aug 2023.
  38. National Institute for Health & Care Excellence (NICE). Venous thromboembolic diseases: Diagnosis, management and thrombophilia testing. NICE. https://www.nice.org.uk/. 02 Aug 2023. Accessed 04 Jul 2024.
  39. Weinberg A, Rali P. Treatment, prognosis, and follow-up of acute pulmonary embolism in adults. UpToDate. https://www.uptodate.com/. 16 Feb 2024.
  40. Götzinger F, Lauder L, Sharp ASP, et al. Interventional therapies for pulmonary embolism. Nat Rev Cardiol. 2023 Oct;20(10):670-684. doi: 10.1038/s41569-023-00876-0. Accessed 04 Jul 2024. PMID: 37173409
  41. Rivera-Lebron B, Weinberg A. Approach to thrombolytic (fibrinolytic) therapy in acute pulmonary embolism: Patient selection and administration. UpToDate. https://www.uptodate.com/. 15 Dec 2023.